Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Degertekin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|January 30, 2009
Do guidelines preclude hepatitis B patients from receiving treatment?Bulent Degertekin, Anna S Lok
Current Opinion in Gastroenterology|April 15, 2008
Update on viral hepatitis: 2007Bulent Degertekin, Anna Sf Lok
Journal of Hepatology|April 25, 2008
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?Bulent Degertekin, Anna S Lok
Nature Clinical Practice. Gastroenterology & Hepatology|December 19, 2008
What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?Bulent Degertekin, Anna S Lok
Gastroenterology|October 9, 2008
Should liver biopsies be performed on all hepatitis B carriers?Bulent Degertekin, Anna S Lok
Hepatology (Baltimore, Md.)|April 29, 2009
Indications for therapy in hepatitis BBulent Degertekin, Anna S F Lok
Current Opinion in Gastroenterology|April 24, 2009
Update on viral hepatitis: 2008Bulent Degertekin, Anna S F Lok
Annals of Internal Medicine|July 4, 2007
When to start and stop hepatitis B treatment: can one set of criteria apply to all patients regardless of age at infection?Bulent Degertekin, Anna S F Lok
Digestive Diseases and Sciences|April 13, 2007
The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosisBulent Degertekin, Seren Ozenirler, Sehri Elbeg, et al.
Neurology India|May 15, 2009
Cerebral sinus thrombosis in a patient with active ulcerative colitis and double heterozygosity for Factor V Leiden and prothrombin gene mutationsFahri Yakaryilmaz, Sefa Guliter, Bulent Degertekin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|January 30, 2009
Do guidelines preclude hepatitis B patients from receiving treatment?Bulent Degertekin, Anna S Lok
Current Opinion in Gastroenterology|April 15, 2008
Update on viral hepatitis: 2007Bulent Degertekin, Anna Sf Lok
Journal of Hepatology|April 25, 2008
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?Bulent Degertekin, Anna S Lok
Nature Clinical Practice. Gastroenterology & Hepatology|December 19, 2008
What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?Bulent Degertekin, Anna S Lok
Gastroenterology|October 9, 2008
Should liver biopsies be performed on all hepatitis B carriers?Bulent Degertekin, Anna S Lok
Hepatology (Baltimore, Md.)|April 29, 2009
Indications for therapy in hepatitis BBulent Degertekin, Anna S F Lok
Current Opinion in Gastroenterology|April 24, 2009
Update on viral hepatitis: 2008Bulent Degertekin, Anna S F Lok
Annals of Internal Medicine|July 4, 2007
When to start and stop hepatitis B treatment: can one set of criteria apply to all patients regardless of age at infection?Bulent Degertekin, Anna S F Lok
Digestive Diseases and Sciences|April 13, 2007
The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosisBulent Degertekin, Seren Ozenirler, Sehri Elbeg, et al.
Neurology India|May 15, 2009
Cerebral sinus thrombosis in a patient with active ulcerative colitis and double heterozygosity for Factor V Leiden and prothrombin gene mutationsFahri Yakaryilmaz, Sefa Guliter, Bulent Degertekin, et al.
Pageof 3